Literature DB >> 22528106

Histological staining of amyloid and pre-amyloid peptides and proteins in mouse tissue.

Hameetha B Rajamohamedsait1, Einar M Sigurdsson.   

Abstract

The increased availability of transgenic mouse models for studying human diseases has shifted the focus of many laboratories from in vitro to in vivo assays. Herein, methods are described to allow investigators to obtain well-preserved mouse tissue to be stained with the standard histological dyes for amyloid, Congo Red, and Thioflavin S. These sections can as well be used for immunohistological procedures that allow detection of tissue amyloid and pre-amyloid, such as those composed of the amyloid-β peptide, the tau protein, and the islet amyloid polypeptide.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528106      PMCID: PMC3859432          DOI: 10.1007/978-1-61779-551-0_28

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease.

Authors:  P G Vallet; R Guntern; P R Hof; J Golaz; A Delacourte; N K Robakis; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging.

Authors:  Brian J Cummings; Amy J L Mason; Ronald C Kim; Philip C-Y Sheu; Aileen J Anderson
Journal:  Neurobiol Aging       Date:  2002 Mar-Apr       Impact factor: 4.673

3.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.

Authors:  T Kitamoto; K Ogomori; J Tateishi; S B Prusiner
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

4.  Comparison of four staining methods on the detection of neuritic plaques.

Authors:  H M Wisniewski; G Y Wen; K S Kim
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  A demonstration of the advantages of immunostaining in the quantification of amyloid plaque deposits.

Authors:  S M Gentleman; C Bruton; D Allsop; S J Lewis; J M Polak; G W Roberts
Journal:  Histochemistry       Date:  1989

6.  Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.

Authors:  E M Sigurdsson; H Scholtzova; P D Mehta; B Frangione; T Wisniewski
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

Authors:  L Davies; B Wolska; C Hilbich; G Multhaup; R Martins; G Simms; K Beyreuther; C L Masters
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

8.  Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.

Authors:  Ayodeji A Asuni; Allal Boutajangout; David Quartermain; Einar M Sigurdsson
Journal:  J Neurosci       Date:  2007-08-22       Impact factor: 6.167

9.  Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads.

Authors:  K M Cullen; G M Halliday; H Cartwright; J J Kril
Journal:  Neurodegeneration       Date:  1996-06

10.  Comparison of new and traditional methods for detection of senile plaques in Alzheimer's disease.

Authors:  L S Raskin; M D Applegate; D L Price; J C Troncoso; J C Hedreen
Journal:  J Geriatr Psychiatry Neurol       Date:  1995-04       Impact factor: 2.680

View more
  21 in total

1.  Bio-Evaluation of 99mTc-Labeled Homodimeric Chalcone Derivative as Amyloid-β-Targeting Probe.

Authors:  Garima Mann; Kanchan Chauhan; Vikas Kumar; Shivani Daksh; Nikhil Kumar; M Thirumal; Anupama Datta
Journal:  Front Med (Lausanne)       Date:  2022-06-17

2.  Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease.

Authors:  Melissa K Edler; Chet C Sherwood; Richard S Meindl; William D Hopkins; John J Ely; Joseph M Erwin; Elliott J Mufson; Patrick R Hof; Mary Ann Raghanti
Journal:  Neurobiol Aging       Date:  2017-08-01       Impact factor: 4.673

3.  Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques.

Authors:  Kanchan Bisht; Hassan El Hajj; Julie C Savage; Maria G Sánchez; Marie-Ève Tremblay
Journal:  J Vis Exp       Date:  2016-06-01       Impact factor: 1.355

4.  Modulatory Effects of Ginkgo biloba Against Amyloid Aggregation Through Induction of Heat Shock Proteins in Aluminium Induced Neurotoxicity.

Authors:  Sonia Verma; Sheetal Sharma; Pavitra Ranawat; Bimla Nehru
Journal:  Neurochem Res       Date:  2020-01-02       Impact factor: 3.996

5.  Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer's Disease.

Authors:  Julia Derk; Keria Bermudez Hernandez; Moises Rodriguez; Meilun He; Hyunwook Koh; Andisheh Abedini; Huilin Li; David Fenyö; Ann Marie Schmidt
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  An 8-Week Administration of Bifidobacterium bifidum and Lactobacillus plantarum Combined with Exercise Training Alleviates Neurotoxicity of Aβ and Spatial Learning via Acetylcholine in Alzheimer Rat Model.

Authors:  Samaneh Shamsipour; Gholamreza Sharifi; Farzaneh Taghian
Journal:  J Mol Neurosci       Date:  2021-03-14       Impact factor: 3.444

7.  Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer's disease-risk genes.

Authors:  Zhixiong Ma; Weiliang Jiang; Eric Erquan Zhang
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

8.  A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.

Authors:  Laura Louise Scott; Timothy Grant Downing
Journal:  Toxins (Basel)       Date:  2017-12-29       Impact factor: 4.546

9.  Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy.

Authors:  Erin E Congdon; Yan Lin; Hameetha B Rajamohamedsait; Dov B Shamir; Senthilkumar Krishnaswamy; Wajitha J Rajamohamedsait; Suhail Rasool; Veronica Gonzalez; Josien Levenga; Jiaping Gu; Charles Hoeffer; Einar M Sigurdsson
Journal:  Mol Neurodegener       Date:  2016-08-30       Impact factor: 14.195

10.  Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice.

Authors:  Hameetha Rajamohamedsait; Suhail Rasool; Wajitha Rajamohamedsait; Yan Lin; Einar M Sigurdsson
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.